1009-9921
2010 Issue 11
Expression and significance of interleukin-1β in serum of acute myeloid leukemia
ZHANG Xiu-lian;ZHANG Wei-hua;HOU Su-min;CHEN Wei;TAO Jie
ZHANG Xiu-lian;ZHANG Wei-hua;HOU Su-min;CHEN Wei;TAO Jie
..............page:663-665
Clinical characteristics and treatment analysis of primary ocular adnexal lymphoma
HOU Yi-geng;WANG Hua-qing;QIAN Zheng-zi;ZHANG Hui-lai;LIU Xian-ming;ZHOU Shi-yong;HOU Yun;SONG Zheng;FU Kai
HOU Yi-geng;WANG Hua-qing;QIAN Zheng-zi;ZHANG Hui-lai;LIU Xian-ming;ZHOU Shi-yong;HOU Yun;SONG Zheng;FU Kai
..............page:675-677,681
..............page:前插1
Clinical study of elderly patients with acute promyelocytic leukemia
YUAN Yan-hui;WU De-pei;OUYANG Jian
YUAN Yan-hui;WU De-pei;OUYANG Jian
..............page:672-674
Using Ig/TCR gene rearrangements to monitor minimal residual disease in pediatric lymphoma
XING Yan-ping
XING Yan-ping
..............page:695-698
Clinical value of combined detection of urinary microproteins in acute promyelocytic leukemia with arsenic trioxide in childhood
HAO Liang-chun;ZHAO Ji-shun;WANG Xiu-li;WANG Hong;WANG Huan;XU Gang
HAO Liang-chun;ZHAO Ji-shun;WANG Xiu-li;WANG Hong;WANG Huan;XU Gang
..............page:658-660
Caspase recruitment domain 11 and diffuse large B-cell lymphoma
LIU Fang-fang;GE Jun-hui
LIU Fang-fang;GE Jun-hui
..............page:702-704
fu fang zhe bei ke li lian he ji mu dan kang wei zhu hua liao zhi liao nan zhi xing ji xing sui xi bai xue bing si li
xu ya mei ; hou li ; li dong yun ; jia mei ; dong qing ; bai zuo ; chen xin yi
xu ya mei ; hou li ; li dong yun ; jia mei ; dong qing ; bai zuo ; chen xin yi
..............page:692-694
man xing nk xi bao lin ba zeng zhi xing ji bing yi li bing wen xian fu xi
yang dan ; zhang wei ping ; zhang zuo zuo ; cheng hui
yang dan ; zhang wei ping ; zhang zuo zuo ; cheng hui
..............page:685-687
cheng nian ren still bing he bing shi xue xi bao zong he zheng er li bing wen xian fu xi
wei na ; wang zhao ; xiong mei ; yang ling zhi
wei na ; wang zhao ; xiong mei ; yang ling zhi
..............page:687-689
The responses of arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
XU Lan;CHEN Fang-yuan;HUANG Hong-hui;ZHONG Hua;ZHONG Lu;SHEN Li-jing;ZHU Jian-yi;HAN Jie-ying;CHEN Bing
XU Lan;CHEN Fang-yuan;HUANG Hong-hui;ZHONG Hua;ZHONG Lu;SHEN Li-jing;ZHU Jian-yi;HAN Jie-ying;CHEN Bing
..............page:651-654
chag san lian yu ji fang an you dao huan jie zhi liao nan zhi fu fa xing ji xing sui xi bai xue bing 12 li
mi rui hua ; wei xu dong ; yin qing song ; zhu xing hu
mi rui hua ; wei xu dong ; yin qing song ; zhu xing hu
..............page:682-683
fei yuan fa ping hua ji rou liu pi fu zhuan yi ji fa zhi liao xiang guan ji xing bai xue bing yi li bing wen xian fu xi
ma yan ; chen bo bin ; xu xiao ping ; ji mei rong ; lin guo wei
ma yan ; chen bo bin ; xu xiao ping ; ji mei rong ; lin guo wei
..............page:689-692
Pay attention to the long-term toxicities of therapy on lymphoma
LIU Xia;WANG Hua-qing
LIU Xia;WANG Hua-qing
..............page:641-645
Clinical features of 12 children with chronic myeloid leukemia
LIU Zhao-e;SONG Hui-xiao;CHEN Li-jun
LIU Zhao-e;SONG Hui-xiao;CHEN Li-jun
..............page:661-662,665
Investigation of long-term follow-up results of 135 patients with chronic myeloid leukemia receiving imatinib
ZHOU Ke-shu;WANG Cui-cui;ZHAO Yao-zhong;Xing Li-jie;QIAN Lin-sheng;YU Zhen;QI Jun-yuan;WANG Jian-xiang;QIU Lu-gui
ZHOU Ke-shu;WANG Cui-cui;ZHAO Yao-zhong;Xing Li-jie;QIAN Lin-sheng;YU Zhen;QI Jun-yuan;WANG Jian-xiang;QIU Lu-gui
..............page:646-650
Research progress of CD+4 CD+25 Foxp3+ regulatory T cell in T cell non-Hodgkin lymphoma
LIU Zeng-hui
LIU Zeng-hui
..............page:698-701
Analysis of outcome and prognosis-related factors of MA regimen for acute myeloid leukemia
SUN Hai-ying;GENG Hua-yun;ZHANG Pu;YANG Yu-juan;YAN Zhi-ling;XU Kai-lin
SUN Hai-ying;GENG Hua-yun;ZHANG Pu;YANG Yu-juan;YAN Zhi-ling;XU Kai-lin
..............page:669-671
Study on the aberrant methylation of SOCS-1 gene in diffuse large B-cell lymphoma
DOU Hong-ju;HU Jun-pei;TANG Yong;WANG Ming-ming;ZHUANG Yan;ZHU Qi;ZHAO Wei-li
DOU Hong-ju;HU Jun-pei;TANG Yong;WANG Ming-ming;ZHUANG Yan;ZHU Qi;ZHAO Wei-li
..............page:678-681
Clinical investigation of treatment with Qinghuang powder for 86 patients with chronic myelogenous leukemia
ZHOU Ai-xiang;CHENG Zhi-wei;MA Rou;DENG Cheng-shan;LIU Feng;HU Xiao-mei;HU Nai-ping
ZHOU Ai-xiang;CHENG Zhi-wei;MA Rou;DENG Cheng-shan;LIU Feng;HU Xiao-mei;HU Nai-ping
..............page:655-657
Clinical observsion on hyperhydration, forced diuresis and alkalinizing plus infusion mesna in the prevention of hemorrhagic cystitis after hematopoietic stem cell transplantation
CHEN Ling-zhen;CHEN Jia-yu;WU Jin-ming;YU Wei;ZHAN Yu
CHEN Ling-zhen;CHEN Jia-yu;WU Jin-ming;YU Wei;ZHAN Yu
..............page:666-668,671
mi man da b xi bao lin ba liu zhong shu shen jing xi tong jin run yi li bing wen xian fu xi
wang lie yang ; su li ping ; li zuo ru ; wang hai xia
wang lie yang ; su li ping ; li zuo ru ; wang hai xia
..............page:683-685